- Home
- APVO vs ELWS Comparison
APVO vs ELWS Comparison
Compare APVO & ELWS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APVO
- ELWS
- Stock Information
- Founded
- APVO 2016
- ELWS 2018
- Country
- APVO United States
- ELWS Japan
- Employees
- APVO N/A
- ELWS N/A
- Industry
- APVO Biotechnology: Pharmaceutical Preparations
- ELWS
- Sector
- APVO Health Care
- ELWS
- Exchange
- APVO Nasdaq
- ELWS Nasdaq
- Market Cap
- APVO 6.5M
- ELWS 6.2M
- IPO Year
- APVO N/A
- ELWS 2023
- Fundamental
- Price
- APVO $4.46
- ELWS $2.94
- Analyst Decision
- APVO Strong Buy
- ELWS
- Analyst Count
- APVO 1
- ELWS 0
- Target Price
- APVO $296.00
- ELWS N/A
- AVG Volume (30 Days)
- APVO 90.6K
- ELWS 22.5K
- Earning Date
- APVO 03-04-2025
- ELWS 12-31-2024
- Dividend Yield
- APVO N/A
- ELWS N/A
- EPS Growth
- APVO N/A
- ELWS N/A
- EPS
- APVO N/A
- ELWS N/A
- Revenue
- APVO N/A
- ELWS $1,139,113.00
- Revenue This Year
- APVO N/A
- ELWS N/A
- Revenue Next Year
- APVO N/A
- ELWS N/A
- P/E Ratio
- APVO N/A
- ELWS N/A
- Revenue Growth
- APVO N/A
- ELWS 285.14
- 52 Week Low
- APVO $3.65
- ELWS $1.04
- 52 Week High
- APVO $399.60
- ELWS $13.00
- Technical
- Relative Strength Index (RSI)
- APVO 38.21
- ELWS 51.71
- Support Level
- APVO $4.32
- ELWS $2.75
- Resistance Level
- APVO $4.79
- ELWS $2.99
- Average True Range (ATR)
- APVO 0.45
- ELWS 0.20
- MACD
- APVO 0.15
- ELWS 0.00
- Stochastic Oscillator
- APVO 19.53
- ELWS 51.61
About APVO Aptevo Therapeutics Inc.
Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using ADAPTIR modular protein technology platform. The versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.
About ELWS Earlyworks Co. Ltd.
Earlyworks Co Ltd is a blockchain-based technology company. It builds products, delivers services, and develops solutions based on a proprietary grid ledger system to leverage blockchain technology in various business settings, including advertisement tracking, online visitor management, and sales of non-fungible tokens. The company's customers represent a diverse range of industries, such as information technology, shipping, real estate, entertainment, cosmetics, and chemical products.